Tarsus Pharmaceuticals, Inc. TARS Intangible Assets Gross (Excluding Goodwill)
Intangible Assets Gross (Excluding Goodwill) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s intangible assets gross (excluding goodwill).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s intangible assets gross (excluding goodwill)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported intangible assets gross (excluding goodwill) of $9M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s intangible assets gross (excluding goodwill) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s intangible assets gross (excluding goodwill) decreased by 0.0% year-over-year, from $9M to $9M.
- What does intangible assets gross (excluding goodwill) mean?
- This metric aggregates the gross carrying amount of all identifiable intangible assets, excluding goodwill. It provides a clearer picture of the company's investment in specific, separable assets like patents, software, and customer relationships. It is a key measure of the company's non-physical asset base.